Nocera, Inc. (NCRA) - Form 8-K Summary
Business Context and Reporting Period
Nocera, Inc., a Nevada corporation trading on the Nasdaq Stock Market under the symbol NCRA, filed this Current Report on Form 8-K on April 3, 2025. The filing addresses a material restatement of unaudited interim consolidated financial statements for the quarterly periods ended March 31, 2024, June 30, 2024, and September 30, 2024 (the "Restated Periods").
Key Financial Metrics and Material Changes
The filing discloses material errors in the accounting for warrant liabilities, resulting in significant misstatements in previously reported figures:
- Accounting Error: The Company failed to recognize a decrease in the fair value of its warrant liability totaling $552,173 during the Restated Periods, contrary to ASC 815-40-35-4 and ASC 825-10-45-5.
- Balance Sheet Impact: As of September 30, 2024, the warrant liability was overstated by approximately 70%, and total liabilities were overstated by approximately 35%.
- Income Statement Impact: The error materially impacted the reported net loss for 2024, which was previously stated as $1.16 million.
- Internal Controls: Management concluded that a material weakness existed in internal controls over financial reporting regarding the evaluation and measurement of warrant liabilities and the reversal of liabilities during the Restated Periods.
The filing does not provide updated revenue, cash flow, or margin figures for the current period, as the focus is on the correction of prior period errors.
Outlook, Management Commentary, and Risks
Management has determined that prior conclusions regarding the effectiveness of disclosure controls and procedures for the Restated Periods should no longer be relied upon. The Company intends to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, on or before April 15, 2025. This report will include:
- Restated financial statements for the Restated Periods presented as footnotes.
- An explanatory note detailing the background and impact of the restatements.
- An updated evaluation confirming that disclosure controls and internal controls were not effective as of the end of the Restated Periods due to identified material weaknesses.
The Company has discussed these matters with its independent registered public accounting firm, Enrome LLP.
Investor Verification Checklist
- Verify the corrected net loss figure for 2024 once the Form 10-K is filed.
- Review the restated balance sheet to confirm the adjusted warrant liability and total liability figures.
- Monitor the Company's remediation plan for the identified material weakness in internal controls.
- Confirm the filing date of the 2024 Form 10-K (expected by April 15, 2025).